Infants who consume formula containing milk fat globule membrane score higher in developmental test as they grow older, according to a new Mead Johnson backed study.
Reckitt Benckiser Group plc (RB) has confirmed it is in ‘advanced negotiations’ to acquire all Mead Johnson Nutrition shares for $90 each in cash, valuing Mead Johnson’s entire share capital at approximately $16.7bn.
Mead Johnson Nutrition has signed an agreement with Swiss company Ewopharma, a distributor of pharmaceutical and nutritional products in Central Eastern Europe, to launch Nutramigen PURAMINO in Czechia and Slovakia.
Mead Johnson Nutrition has agreed to pay $12m (€10.9m) to settle a US Securities and Exchange Commission (SEC) investigation into the "promotional practices" of its Chinese business.
Mead Johnson Nutrition has revealed that the US Securities and Exchange Commission (SEC) is probing “certain expenditures” relating to the promotion of infant formula products by its business in China.